Literature DB >> 27579136

Acute myocardial infarction in the obstetric patient.

Tabassum Firoz1, Laura A Magee1.   

Abstract

Acute myocardial infraction (AMI) in the obstetric patient is a rare event, although the incidence is rising due to advancing maternal age and pre-existing cardiac risk factors and medical co-morbidities. While atherosclerotic disease is the leading cause of AMI, coronary artery dissection is an important consideration in pregnancy and in the postpartum period. The physiological changes of pregnancy as well as pregnancy-specific risk factors can predispose the obstetric patient to AMI. Diagnosis of AMI can be challenging as symptoms may be atypical. Furthermore, diagnostic tests must be interpreted in the context of pregnancy. While the overall management of the obstetric patient with AMI is similar to that outside of pregnancy, drug therapy requires modification as some medications may be contraindicated in pregnancy and breastfeeding. There is limited information about prognosis and risk stratification but it is anticipated that future studies will address this issue.

Entities:  

Keywords:  cardiovascular disease; maternal morbidity; myocardial infarction; pregnancy

Year:  2012        PMID: 27579136      PMCID: PMC4989614          DOI: 10.1258/om.2011.011080

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  60 in total

1.  Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis.

Authors:  P von Dadelszen; M P Ornstein; S B Bull; A G Logan; G Koren; L A Magee
Journal:  Lancet       Date:  2000-01-08       Impact factor: 79.321

Review 2.  Coronary artery dissection during pregnancy and the postpartum period: two case reports and review of literature.

Authors:  A K Koul; G Hollander; N Moskovits; R Frankel; L Herrera; J Shani
Journal:  Catheter Cardiovasc Interv       Date:  2001-01       Impact factor: 2.692

3.  Prospective multicenter study of pregnancy outcomes in women with heart disease.

Authors:  S C Siu; M Sermer; J M Colman; A N Alvarez; L A Mercier; B C Morton; C M Kells; M L Bergin; M C Kiess; F Marcotte; D A Taylor; E P Gordon; J C Spears; J W Tam; K S Amankwah; J F Smallhorn; D Farine; S Sorensen
Journal:  Circulation       Date:  2001-07-31       Impact factor: 29.690

4.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.

Authors:  E M Antman; M Cohen; P J Bernink; C H McCabe; T Horacek; G Papuchis; B Mautner; R Corbalan; D Radley; E Braunwald
Journal:  JAMA       Date:  2000-08-16       Impact factor: 56.272

Review 5.  The evolving role of statins in the management of atherosclerosis.

Authors:  C J Vaughan; A M Gotto; C T Basson
Journal:  J Am Coll Cardiol       Date:  2000-01       Impact factor: 24.094

6.  beta Blockade after myocardial infarction: systematic review and meta regression analysis.

Authors:  N Freemantle; J Cleland; P Young; J Mason; J Harrison
Journal:  BMJ       Date:  1999-06-26

7.  Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.

Authors:  S R Mehta; S Yusuf; R J Peters; M E Bertrand; B S Lewis; M K Natarajan; K Malmberg; H Rupprecht; F Zhao; S Chrolavicius; I Copland; K A Fox
Journal:  Lancet       Date:  2001-08-18       Impact factor: 79.321

Review 8.  Medications in the breast-feeding mother.

Authors:  J P Spencer; L S Gonzalez; D J Barnhart
Journal:  Am Fam Physician       Date:  2001-07-01       Impact factor: 3.292

9.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

Authors:  J S Alpert; K Thygesen; E Antman; J P Bassand
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

10.  Acute myocardial infarction in the young--The University of Michigan experience.

Authors:  Michele Doughty; Raj Mehta; David Bruckman; Sugata Das; Dean Karavite; Thomas Tsai; Kim Eagle
Journal:  Am Heart J       Date:  2002-01       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.